114 related articles for article (PubMed ID: 9619692)
1. Effects of serotonin and metergoline on 125[I]-iodocyanopindolol binding parameters to beta-adrenergic receptors in rat brain.
Gurguis GN; Turkka J; Linnoila M
Eur Neuropsychopharmacol; 1998 May; 8(2):131-40. PubMed ID: 9619692
[TBL] [Abstract][Full Text] [Related]
2. Application of [125I]iodocyanopindolol to measure 5-hydroxytryptamine1B receptors in the brain of the rat.
Offord SJ; Ordway GA; Frazer A
J Pharmacol Exp Ther; 1988 Jan; 244(1):144-53. PubMed ID: 3335996
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol.
Hoyer D; Engel G; Kalkman HO
Eur J Pharmacol; 1985 Nov; 118(1-2):1-12. PubMed ID: 3002805
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced regulation of [125I]iodocyanopindolol-labeled 5-hydroxytryptamine1B receptor binding sites in the central nervous system.
Pranzatelli MR; Razi P
Neuropsychopharmacology; 1994 Jul; 10(4):259-64. PubMed ID: 7945736
[TBL] [Abstract][Full Text] [Related]
5. G protein dependent alterations in [125I]iodocyanopindolol and +/- cyanopindolol binding at 5-HT1B binding sites in rat brain membranes.
Ariani K; Hamblin MW; Tan GL; Stratford CA; Ciaranello RD
Neurochem Res; 1989 Sep; 14(9):835-43. PubMed ID: 2512511
[TBL] [Abstract][Full Text] [Related]
6. Genetic influences on agonist binding to cardiac beta-receptors.
Christ GJ; Dunlap CE; Blizard DA
Biochem Pharmacol; 1988 Apr; 37(7):1281-6. PubMed ID: 2895654
[TBL] [Abstract][Full Text] [Related]
7. The characterization of beta adrenoceptor subtypes in the rat amygdala and hippocampus.
Tiong AH; Richardson JS
Int J Neurosci; 1990 Oct; 54(3-4):231-44. PubMed ID: 1979972
[TBL] [Abstract][Full Text] [Related]
8. Post-natal evolution of rat cardiac beta-adrenoceptors.
Cros GH; Chanez PO; Michel A; Boucard M; Serrano JJ
Life Sci; 1988; 43(8):699-706. PubMed ID: 2842565
[TBL] [Abstract][Full Text] [Related]
9. Three binding sites of 125I-iodocyanopindolol, i.e. beta 1, beta 2-adrenergic and 5HT1B-serotonergic receptors in rat brain determined by the displacement and Scatchard analysis.
Tsuchihashi H; Nagatomo T; Imai S
J Pharmacobiodyn; 1989 Sep; 12(9):509-16. PubMed ID: 2559184
[TBL] [Abstract][Full Text] [Related]
10. Characterization of rat cerebral cortical beta adrenoceptor subtypes using (-)-[125I]-iodocyanopindolol.
Tiong AH; Richardson JS
J Recept Res; 1989-1990; 9(6):495-508. PubMed ID: 2577008
[TBL] [Abstract][Full Text] [Related]
11. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
Hoyer D; Engel G; Kalkman HO
Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
[TBL] [Abstract][Full Text] [Related]
12. The anti-aggressive drug eltoprazine preferentially binds to 5-HT1A and 5-HT1B receptor subtypes in rat brain: sensitivity to guanine nucleotides.
Sijbesma H; Schipper J; De Kloet ER
Eur J Pharmacol; 1990 Oct; 187(2):209-23. PubMed ID: 2272361
[TBL] [Abstract][Full Text] [Related]
13. Homogeneous class of beta-1 adrenergic receptors in rat kidney. Identification by (+/-)-125 iodocyanopindolol binding.
Brodde OE
Biochem Pharmacol; 1982 May; 31(9):1743-7. PubMed ID: 6285932
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of 125I-iodocyanopindolol binding to beta-adrenergic and serotonin-1B receptors of rat brain: selectivity of beta-adrenergic agents.
Tsuchihashi H; Nakashima Y; Kinami J; Nagatomo T
Jpn J Pharmacol; 1990 Feb; 52(2):195-200. PubMed ID: 1968985
[TBL] [Abstract][Full Text] [Related]
15. Specific non-beta-adrenergic binding sites for 125I-iodocyanopindolol in myocardial membrane preparations: a comparative study between human, rat, and porcine hearts.
Bjørnerheim R; Golf S; Hansson V
Cardiovasc Res; 1991 Sep; 25(9):764-73. PubMed ID: 1666020
[TBL] [Abstract][Full Text] [Related]
16. Labelling of rat brain beta-adrenoceptors: (3H)CGP-12177 or (125I)iodocyanopindolol?
Morin D; Zini R; Urien S; Sapena R; Tillement JP
J Recept Res; 1992; 12(3):369-87. PubMed ID: 1354747
[TBL] [Abstract][Full Text] [Related]
17. Absence of high-affinity binding sites for beta-adrenergic blockers and lack of adenyl cyclase stimulation to beta-adrenergic stimulators in most normal and adenomatous human thyroid tissues.
Goretzki PE; Wahl RA; Branscheid D; Roeher HD
Surgery; 1984 Dec; 96(6):1001-8. PubMed ID: 6150553
[TBL] [Abstract][Full Text] [Related]
18. Indices of brain beta-adrenergic receptor signal transduction in the learned helplessness animal model of depression.
Gurguis GN; Kramer G; Petty F
J Psychiatr Res; 1996; 30(2):135-46. PubMed ID: 8816307
[TBL] [Abstract][Full Text] [Related]
19. Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release.
Matsumoto I; Combs MR; Jones DJ
J Pharmacol Exp Ther; 1992 Feb; 260(2):614-26. PubMed ID: 1738111
[TBL] [Abstract][Full Text] [Related]
20. Selectivity of bunitrolol for beta 1- and beta 2-adrenergic receptors and 5HT1B-receptors: assessment by biphasic Scatchard plots and biphasic displacement curve analysis with 125I-iodocyanopindolol and 3H-CGP12177.
Tsuchihashi H; Nagotomo T; Imai S
Jpn J Pharmacol; 1989 Jun; 50(2):93-100. PubMed ID: 2570175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
